1. Merkel PA, Silliman NP, Clements PJ, Denton CP, Furst DE, Mayes MD, et al. Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis. Arthritis Rheum. 2012 Oct;64(10):3420–9.
2. Hoogewerf CJ, van Baar ME, Middelkoop E, van Loey NE. Patient reported facial scar assessment: directions for the professional. Burns. 2014 Mar;40(2):347–53.
3. Chen N, Guo D, Guo Y, Sun Y, Bi H, Ma X. Paclitaxel inhibits cell proliferation and collagen lattice contraction via TGF-β signaling pathway in human tenon’s fibroblasts in vitro. Eur J Pharmacol. 2016 Apr 15;777:33–40.
4. Strange K. Of mice and worms: novel insights into ClC-2 anion channel physiology. News Physiol Sci. 2002 Feb;17:11–6.
5. Lu J, Xu F, Zhang Y, Lu H, Zhang J. ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway. Cell Mol Biol Lett. 2018;23:29.